Sublingual immunotherapy with recombinant Mal d 1 downregulates the allergen‐specific Th2 response

類似資料

• Adjuvants and Vaccines Used in Allergen-Specific Immunotherapy Induce Neutrophil Extracellular Traps
  著者:: Karacs, Jasmine, 等
  出版事項: (2021)
• NSG mice humanized with allergen‐specific T‐cell lines as in vivo model of respiratory allergy
  著者:: Vizzardelli, Caterina, 等
  出版事項: (2020)
• Recombinant Mal d 1 facilitates sublingual challenge tests of birch pollen‐allergic patients with apple allergy
  著者:: Kinaciyan, T., 等
  出版事項: (2015)
• Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy
  著者:: Marth, Katharina, 等
  出版事項: (2014)
• Adjuvanting Allergen Extracts for Sublingual Immunotherapy: Calcitriol Downregulates CXCL8 Production in Primary Sublingual Epithelial Cells
  著者:: Pelst, Michael P., 等
  出版事項: (2020)